Amarpreet Sawhney is the President and CEO of Ocular Therapeutix, a company that specializes in ophthalmic surgical wound management and drug delivery. Before that, he founded and led Confluent Surgical, a biosurgery company that was acquired by Covidien. He was also the Chairman of MarketRx, a pharmaceutical marketing and sales analytics provider that was acquired by Cognizant. Dr. Sawhney has founded and is a member of the board of several companies, including Ostial Corp., TiE Boston, Ocular Therapeutix, Augmenix, and Incept LLC. He has also received numerous awards, including the MassDevice “Five Most Innovative Medical Device CEOs” award and the MIT Global Indus Technovators Award. Dr. Sawhney has a Ph.D. and M.S. in Chemical Engineering from the University of Texas at Austin and a B.Tech. in Chemical Engineering from IIT Delhi.